Clinical Outcome of Low-Grade Myofibroblastic Sarcoma in Japan: A Multicenter Study from the Japanese Musculoskeletal Oncology Group
Munehisa Kito(Japanese Foundation For Cancer Research), Hirotaka Kawano(Teikyo University), Shusa Ohshika(Hirosaki University), K. Ikuta(Nagoya University), Masanori Okamoto(Shinshu University), Taketoshi Yasuda(University of Toyama), Makoto Endo(Kyushu University), Yutaka Nezu, Teruya Kawamoto(Konan University), Kazutaka Kikuta(Tochigi Cancer Center), Takafumi Ueda(The University of Osaka), Takeshi Uehara(Shinshu University Hospital), Akihiko Takeuchi(Yale University), Naohiro Yasuda(The University of Osaka), Keisuke Ae(The Cancer Institute Hospital), Takeshi Morii(Kyorin University), Ichiro Baba(Osaka Medical and Pharmaceutical University), Jun Takahashi(Shinshu University), Yoshinori Imura(Osaka University)
Cited by 11
Related Papers
Clear Cell Sarcoma of Soft Tissue
|The American Journal of Surgical Pathology|2008|283
Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
|Proceedings of the National Academy of Sciences|2018|264
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein
|Cancer Cell|2015|219
Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis
|Scientific Reports|2014|162
Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome
|Human Mutation|2010|158